TIA Pipeline Accelerator Voucher 2019-2020 - Cancuravax

Project Member(s): Ralph, P.

Funding or Partner Organisation: Department of Innovation, Industry, Science & Research (National Collaborative Research Infrastructure Strategy)
Therapeutic Innovation Australia (Australian Therapeutic Pipeline)
Cancuravax Pty Ltd
Cancuravax Pty Ltd

Start year: 2021

Summary: Melanoma Cancer Vaccine Immunotherapy Production & Scaling for Commercialisation

FOR Codes: Medical molecular engineering of nucleic acids and proteins, Human Pharmaceutical Treatments (e.g. Antibiotics), Human pharmaceutical treatments

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.